Frontlight ResearchEarly access
Duchenne muscular dystrophy trials in Czechia
2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEfficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
- Where
- Prague
- Age
- 9 years to 17 years
- People
- 138 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT05933057 · EU 2023-503521-19-00 - No phaseActive, not recruitingAssessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
- Where
- Prague
- Age
- 1 year to 80 years
- People
- 300 worldwide
- Run by
- Centre Hospitalier Universitaire de Liege
See details and how to joinNCT05982119